secwatch.observer — SEC 8-K summary
======================================

Issuer:     NU SKIN ENTERPRISES, INC. (NUS)
CIK:        0001021561
Form:       8-K
Filed at:   2021-10-04T23:59:59+00:00
Accession:  0001140361-21-033451
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nu Skin estimates Q3 revenue $637-642M, below expectations due to delta variant disruptions
--------------------------------------------------------------------------------

- Estimated Q3 2021 revenue between $637M and $642M, softer than anticipated.
- Delta variant caused unexpected disruptions, especially in Mainland China and Southeast Asia, impacting sales and promotions.
- U.S. Collagen+ launch drove strong growth; Tencent digital tools introduced in China during the quarter.
- Full Q3 results and revised 2021 guidance to be announced on November 3, 2021.
- Annual 2021 revenue expected to be up modestly year over year, management remains confident in strategy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1021561/000114036121033451/0001140361-21-033451-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1021561/000114036121033451/brhc10029555_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-21-033451

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer